ADM — Archer-Daniels-Midland Company

The tape is unambiguously bullish: ADM is up 8.77% in the month and 20.48% in six months as of 2026-09-13, and has touched new 52-week highs on a Q2 2026 print (filed 2026-08-04) that beat consensus ($1.84 adjusted EPS vs ~$1.49 expected) on a 129% year-over-year jump in Ag Services & Oilseeds operating profit to $867M. Management then raised full-year 2026 adjusted EPS guidance to $5.15–$5.60 from $4.15–$4.70 — roughly a $1.00 midpoint raise — and announced further North American crush expansion on 2026-07-30 plus a new COO on 2026-07-20. The one clear divergence: the sell side has not chased. Consensus rating is still Hold (12 buy / 22 hold / 2 sell), the average price target of $79.67 and recent average of $81 both sit BELOW the $86.72 share price, with Barclays' raised $90 (Equal Weight) and a $95 high the exceptions. So sentiment is bullish on fundamentals and price, but the analyst community is explicitly saying the equity has outrun their models.

This is an inflection off a cyclical trough, not a blip. Revenue slid from $22.98B in Q4 2023 to $18.56B in Q4 2025 (a -13.7% YoY quarter), and gross margin compressed from 8.34% in Q3 2023 to 4.70% in Q2 2025, dragging diluted EPS from $1.52 (Q3 2023) to $0.22 (Q3 2025). The turn is now visible across three straight quarters: Q1 2026 revenue +1.6% YoY with $0.62 EPS, Q4 2025 holding $0.94 EPS on a weak revenue base, and Q2 2026 exploding to $22.68B revenue (+7.0% YoY), $896M operating income (vs $100M a year earlier), $1.935B gross profit (8.53% margin — the best in the 12-quarter dataset) and $1.87 diluted EPS, the highest single quarter in three years. Trailing-twelve-month EPS sits at $3.65 versus $2.27 a year ago, +61%. The honest caveat: TTM revenue is still roughly flat (-0.8% YoY) and the recovery is almost entirely margin- and spread-driven, which is inherently cyclical rather than structural volume growth.

As of 2026-09-13, at $86.72, ADM looked rich on trailing numbers and reasonable on forward numbers. Trailing P/E was 23.8x on EPS of $3.649 versus a 5-year average P/E of 15.38x — a ~55% premium — and price/sales of 0.51x versus a 5-year average of 0.40x. Both are genuine premiums and the reason the deterministic model tags the stock 'Rich vs. its own history.' But the trailing base is trough-depressed: on FY2026 consensus EPS of $5.372 the forward P/E is only ~16.1x, a modest premium to the 15.38x historical average and a reasonable price for a business whose earnings are genuinely recovering. The TTM PEG of 0.4 looks cheap but is an artifact of a depressed trailing denominator (TTM earnings are still catching up to the recovery). Dividend yield of 2.56% is decent but not a bargain signal for a 2.5% operating-margin business. Verdict: fair-to-slightly-expensive — you are no longer being paid to take the cyclical risk.

The market is paying ~16x the guided FY2026 midpoint of $5.375 while consensus EPS estimates were revised sharply upward only after the 2026-08-04 print — meaning the stock has front-run the estimate revisions, not the other way around. That is defensible IF $5.37 is a new baseline for earnings rather than a cyclical peak. Compare the history: ADM earned roughly $7.60 in 2022 and ~$6.98 in 2023, then ~$2.22 in 2025 — so $5.37 sits between trough and peak. Paying 16x a mid-cycle number is fair; paying 16x what turns out to be a peak number is expensive. On a normalized $4.50 through-cycle EPS at 15x, the stock would be worth ~$68, while a durable $5.50 at 16.5x implies ~$91. The Q3 2026 release (tentatively mid-November 2026) is the decisive evidence either way — watch crush margins and autumn harvest execution.

As of 2026-09-13, ADM's RSI-14 stood at 64.55 — strong momentum but not yet overbought (>70). Price was +5.12% above the 20-day SMA (roughly $82.5), +6.10% above the 50-day SMA (roughly $81.7), and +19.34% above the 200-day SMA (roughly $72.7), with a six-month return of +20.48%. This is a mature, extended uptrend near the top of the $55.58–$88.75 52-week range. Entry-timing implication: buying at $86.72 is chasing. The 20/50-day cluster around $81–83 is the first logical support and coincidentally lines up with my fair-value estimate and with the recent average analyst target of $81 — a pullback into that zone would be a materially better entry than the current price. A decisive break below the 200-day near $72.7 would signal the recovery trade has failed.

• U.S. biofuel policy: finalized Renewable Volume Obligations under the Renewable Fuel Standard are the single biggest driver of ADM's crush and ethanol margins — any softening, delay, or legal challenge to mandated volumes hits Ag Services & Oilseeds profitability directly.
• Energy prices: elevated global energy prices support ethanol/biodiesel economics and therefore crush spreads, but also raise ADM's own freight, drying, and input costs — the net effect is positive but not one-for-one.
• Global grain trade flows: South American export competition, shifting trade corridors, tariffs, and logistics costs reshape origination and export margins; ADM's global asset base lets it pivot, but it does not remove the margin volatility.
• Interest rates and the farm economy: rates influence farmer selling/storage decisions, ADM's working-capital financing costs, and interest expense on ~$6.45B of long-term debt — plus the stock's 0.613 beta makes it sensitive to rate-driven rotation into and out of defensives.
• Consumer staples sector rotation: with ADM up 50%+ YTD while the broader staples group lags, it has become a momentum name inside a defensive sector — vulnerable if investors rotate back toward classic bond-proxy staples or if growth expectations elsewhere improve.

• Q3 2026 earnings, tentatively mid-November 2026: the first real read on autumn harvest execution and whether Q2's crush/ethanol margins are durable — a second beat would validate the raised $5.15–$5.60 guidance and likely pull analyst targets up toward the share price.
• North American oilseed crush capacity expansion announced 2026-07-30: incremental crush volume aimed at structural biofuel demand; capex updates and commissioning timelines are the milestones to track.
• Sell-side catch-up: consensus is still Hold with an average target of $79.67 and a recent average of $81, both below the $86.72 price — a wave of upward revisions (Barclays already went to $90) would remove a visible valuation overhang.
• Biofuel/RVO rulemaking: any strengthening or expansion of U.S. renewable fuel mandates would be a direct upside catalyst to crush margins.
• Resolution or closure of the SEC investigation tied to the former CFO and past accounting — removing the governance discount is the single largest re-rating lever not captured anywhere in the trailing financials.

• Cyclicality is the core risk: the Q2 2026 earnings surge is margin/spread-driven, and ADM's own history (roughly $7.60 EPS in 2022 versus ~$2.22 in 2025) shows how violently earnings swing with crush and ethanol margins — $5.37 may prove a peak rather than a baseline.
• Valuation risk after a 50%+ YTD run: at $86.72 the stock trades at 23.8x trough-inflated TTM earnings and 16.1x forward EPS versus a 15.38x 5-year average P/E, with the average analyst target of $79.67 below the market price — there is little margin of safety if guidance slips.
• Governance/accounting overhang: ongoing SEC scrutiny of past accounting and the former CFO keeps the multiple below peers and could produce further disclosure or restatement news at any time.
• Structurally thin margins: 2.5% TTM operating margin, 6.9% gross margin, and 3.5% ROIC mean small changes in spreads or volumes move net income disproportionately.
• Erratic, working-capital-driven cash flow: quarterly FCF swung from +$1.513B (Q3 2025) to -$669M (Q4 2025) to +$877M (Q2 2026); the ~50% YoY decline in operating cash flow is a key reason the deterministic growth score is weak and could persist.
• Technical extension: price sits 19.3% above the 200-day SMA and within ~2% of the 52-week high, so any disappointment in Q3 could trigger a sharp mean-reversion move toward the $81–83 support cluster.

ADM is a genuinely improving cyclical, not a value trap — Q2 2026's $1.87 EPS, the 129% jump in Ag Services & Oilseeds operating profit, the 8.53% gross margin, and the ~$1.00 guidance raise are real and policy-supported. But the market has already paid for most of it: at $86.72 the stock is 19% above its 200-day SMA, above the $79.67 average analyst target, and above my own fair-value estimate of ~$83. This is not a fresh-buy-at-the-high situation; the risk/reward is roughly balanced with a better entry available on a pullback into the low $80s, where the 20/50-day moving averages and my valuation work converge.

Applied a 15.5x forward P/E — a modest premium to ADM's 15.38x 5-year average trailing P/E, justified by the confirmed earnings recovery and policy-supported crush/ethanol demand, but discounted for 2.5% operating margins, 3.5% ROIC, and the unresolved SEC/governance overhang — to FY2026 consensus EPS of $5.372, yielding ~$83.3. Cross-checked against a dividend-yield approach: the $2.22/share annualized dividend (2.563% yield on the $86.72 price as of 2026-09-13) at ADM's roughly 2.7% mid-cycle yield implies ~$82, and against the recent average analyst target of $81; I set the figure at $83.